[Indices of lipid peroxidation and atherogenic blood lipoproteins in patients with coronary heart disease receiving antioxidants in addition to basic therapy].
The article substantiates the necessity to administer the antioxidants--vitamins E and ascorbic acid--to patients suffering from coronary heart disease with type II hyperlipoproteinemia in addition to basic therapy, and demonstrates their efficacy and safety. The authors discuss the mechanism of the positive effect of these antioxidants on lipid peroxidation and the blood content of atherogenic lipoproteins.
Reĭzin
A B
AB
Tel'nykh
Iu V
IuV
D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000150:complications / Q000188:drug therapy; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome
D000975:Antioxidants; D015415:Biomarkers; D002317:Cardiovascular Agents; D008074:Lipoproteins